opgH catalyzes the transfer of glucose from UDP-glucose to form linear β-1,2-glucans, which are later branched by associated proteins like OpgG . Key steps include:
Substrate Binding: UDP-glucose binds to a conserved pocket in the cytoplasmic domain .
Glucose Transfer: The catalytic D300 residue deprotonates the acceptor glucose, enabling nucleophilic attack on UDP-glucose .
Polymerization: Processive elongation generates glucan chains of 5–13 residues, exported to the periplasm .
OPGs stabilize bacterial membranes under osmotic stress. opgH mutants fail to produce OPGs, leading to reduced pathogenicity in pathogens like Pseudomonas syringae .
In E. coli, opgH delays cell division by sequestering FtsZ polymers at midcell under nutrient-rich conditions. This UDP-glucose-dependent process increases cell size by ~25% .
opgH’s role in cell division is independent of its enzymatic function, a phenomenon termed "moonlighting" . This dual functionality parallels Bacillus subtilis UgtP, despite lacking sequence homology—a hallmark of convergent evolution .
opgH knockout in E. coli reduces cell size by 12–25%, while overexpression causes filamentation (>13 µm cell length) .
UDP-glucose availability modulates opgH’s inhibitory effect on FtsZ polymerization .
opgH and B. subtilis UgtP exemplify convergent evolution: both regulate cell size via glucosyltransferase domains but employ distinct mechanisms (opgH sequesters FtsZ; UgtP disrupts FtsZ oligomerization) .
Mechanistic Studies: Investigating OPG biosynthesis and cell division coupling .
Biotechnological Tools: Engineering osmotic tolerance in industrial microbes .
Drug Development: Targeting opgH in pathogenic bacteria (e.g., Xanthomonas spp.) .
Structural Dynamics: Resolving opgH’s conformational changes during FtsZ interaction.
Therapeutic Targeting: Designing opgH inhibitors to disrupt biofilm formation in pathogens.
Synthetic Biology: Leveraging opgH for engineered glucan production in bioreactors.
Glucosyltransferase H (opgH) functions primarily in the biosynthesis of osmoregulated periplasmic glucans (OPGs), which are oligosaccharides located in the periplasmic space of many Gram-negative bacteria. These glucans are critical for bacterial adaptation to low osmolarity environments and play roles in virulence, biofilm formation, and host-pathogen interactions. Unlike other glucosyltransferases such as Goe1 that influence both glycogen rosette organization and β-1,3-glucan content in fungal cell walls , opgH is specifically involved in bacterial osmoregulation pathways. The enzyme catalyzes the transfer of glucose from activated donor molecules to growing glucan chains, contributing to the structural integrity of periplasmic space under varying osmotic conditions.
Structurally, opgH belongs to the GT-B fold superfamily of glycosyltransferases, characterized by two Rossmann-like domains with a catalytic site situated in the cleft between them. Unlike fungal glucosyltransferases such as Goe1 that may connect β-1,3-glucan and β-1,6-glucan in cell walls , opgH specifically synthesizes linear glucose polymers with β-1,2-linkages as the backbone of OPGs. The enzyme contains distinctive N-terminal membrane-anchoring domains and C-terminal catalytic domains.
Functionally, opgH differs from glucosyltransferases like GtfK (which synthesizes α-1,6-linked glucans ) in its substrate specificity, catalytic mechanism, and regulation. While GtfK from Streptococcus salivarius can synthesize linear (1→6)-α-d-glucan structures without branching , opgH creates β-1,2-linked glucose backbones that can be further modified by other enzymes. The regulation of opgH is also distinctive, being highly responsive to environmental osmolarity changes, unlike many other glucosyltransferases.
Evolutionary analyses reveal that opgH belongs to a conserved family of glucosyltransferases present across diverse Gram-negative bacterial species, particularly within Enterobacteriaceae, Pseudomonadaceae, and related families. While fungal glucosyltransferases like Goe1 evolved to coordinate glycogen rosette localization and cell wall β-glucan synthesis , bacterial opgH evolved to facilitate adaptation to osmotic stress. Sequence alignments show conserved catalytic domains across different bacterial species, suggesting a common ancestral origin.
The catalytic mechanism appears to be conserved, involving similar active site residues to those used by other glycosyltransferases, but with specific substrate binding sites that determine linkage specificity. This evolutionary conservation underscores the fundamental importance of opgH in bacterial survival, particularly in changing osmotic environments frequently encountered during infection cycles or environmental transitions.
The most effective expression system for recombinant opgH production is the E. coli BL21(DE3) strain using the pET vector system, similar to the approach used for GtfK expression . This system provides high yield and allows for control of expression timing through IPTG induction. Key considerations include:
Codon optimization for E. coli, especially if the source opgH gene contains rare codons
Inclusion of affinity tags (His6) at either N- or C-terminus to facilitate purification
Use of promoters with tight regulation (T7) to control expression
Growth at lower temperatures (18-25°C) after induction to enhance protein folding
Addition of osmolytes (0.5M sorbitol, 3mM betaine) to the culture media to improve folding
For membrane-associated variants of opgH, expression in C41(DE3) or C43(DE3) E. coli strains is recommended due to their improved tolerance for membrane protein expression. Alternatively, cell-free expression systems may be utilized for difficult-to-express variants. Purification typically involves immobilized metal affinity chromatography, similar to the method described for GtfK , followed by size exclusion chromatography.
Several complementary analytical methods can effectively assess opgH enzymatic activity:
| Method | Application | Advantages | Limitations |
|---|---|---|---|
| Radiometric assays | Measures transfer of 14C-labeled glucose from UDP-[14C]glucose to acceptor | High sensitivity, quantitative | Requires radioactive materials |
| HPLC analysis | Quantifies products and substrates | Good for reaction kinetics | Lower sensitivity than radiometric methods |
| Mass spectrometry | Identifies products and modifications | Provides structural information | Complex data analysis |
| NMR spectroscopy | Determines linkage type and conformational details | Complete structural analysis of products | Requires larger amounts of sample |
| Colorimetric assays | Measures reaction byproducts | High-throughput potential | Less specific than other methods |
For linkage analysis of the products, both 1H and 13C NMR spectroscopy are particularly valuable, as demonstrated in the analysis of GtfK products where these methods could determine the specific (1→6)-α-d-glucan linear structure . Additional two-dimensional NMR techniques (COSY, HSQC, HMBC) can provide further structural confirmation of the synthesized glucans, allowing researchers to determine linkage patterns precisely, as shown for the linear (1→6)-α-d-glucan produced by GtfK .
For effective mutagenesis studies of opgH catalytic sites:
Begin with bioinformatic analysis to identify conserved residues across related glucosyltransferases
Prioritize residues in predicted active site regions based on structural homology models
Generate single amino acid substitutions using site-directed mutagenesis:
Conservative substitutions to test chemical requirements
Non-conservative substitutions to disrupt function
Alanine scanning of regions of interest
Express and purify mutant proteins using protocols similar to those for GtfK purification
Assess activity using:
End-point measurements of product formation
Initial velocity measurements for kinetic parameters
Binding assays for substrate interaction without catalysis
Analyze results in a systematic table comparing wild-type and mutant enzymes:
| Mutant | Relative Activity (%) | Km (mM) | kcat (s-1) | kcat/Km (mM-1s-1) | Structural Impact |
|---|---|---|---|---|---|
| Wild-type | 100 | [value] | [value] | [value] | None |
| DXD→AXA | [value] | [value] | [value] | [value] | Disrupts metal coordination |
| R120A | [value] | [value] | [value] | [value] | Affects donor binding |
| W200A | [value] | [value] | [value] | [value] | Disrupts acceptor positioning |
This approach allows for a comprehensive understanding of the catalytic mechanism and can be compared with studies on related enzymes like Goe1, which appears to influence both glycogen organization and β-1,3-glucan production in fungal cell walls .
The osmotic environment regulates opgH activity through multiple interconnected mechanisms:
Transcriptional regulation: Promoter activity increases under low osmolarity conditions through regulatory elements responsive to osmotic stress.
Allosteric regulation: High osmolarity induces conformational changes in opgH structure that reduce catalytic efficiency, likely through binding of small molecule effectors such as ionic compounds or compatible solutes.
Protein-protein interactions: Osmotic stress triggers interaction with regulatory proteins that modify opgH activity.
Post-translational modifications: Phosphorylation states of opgH change in response to osmotic conditions, altering activity.
Membrane microdomain localization: Changes in membrane fluidity during osmotic stress affect opgH localization and access to substrates.
Experimental approaches to investigate these mechanisms include:
Comparative structural studies of opgH in different osmotic conditions using hydrogen-deuterium exchange mass spectrometry
Phosphoproteomic analysis to identify regulatory phosphorylation sites
In vitro reconstitution assays with purified components under varying osmolarity
FRET-based assays to monitor conformational changes in real-time
This regulatory complexity differs from constitutively active glucosyltransferases like GtfK, which produces linear (1→6)-α-d-glucan regardless of osmotic conditions .
Substrate recognition in opgH involves sophisticated mechanisms distinct from other glucosyltransferases:
Donor substrate binding: opgH preferentially binds UDP-glucose through a conserved nucleotide-binding fold, with specificity determined by hydrogen bonding networks and hydrophobic interactions in the catalytic pocket.
Acceptor recognition: Unlike GtfK, which creates linear α-(1→6) glycosidic linkages , opgH creates β-1,2-linkages through precise positioning of acceptor hydroxyl groups relative to the anomeric carbon of the donor substrate.
Catalytic mechanism: opgH likely employs an inverting mechanism (changing anomeric configuration) versus the retaining mechanism used by some other glucosyltransferases.
Structural determinants: The opgH active site contains specific loops and residues that create a microenvironment favoring particular acceptor orientations.
Experimental data suggests that chimeric constructs between opgH and related enzymes can alter linkage specificity, indicating that specific domains control substrate recognition. Unlike Goe1, which may connect β-1,3-glucan and β-1,6-glucan in fungal cell walls , opgH has evolved highly specific recognition mechanisms for creating β-1,2 linkages in bacterial periplasmic glucans.
These recognition mechanisms can be studied through:
Crystal structures with substrate analogs
Molecular dynamics simulations
Saturation transfer difference NMR to map binding interfaces
Competitive inhibition assays with substrate derivatives
opgH interacts with multiple proteins in the periplasmic glucan biosynthesis pathway to coordinate glucan synthesis and modification:
Initiator proteins (opgG): Provide primers for opgH to extend, controlling glucan chain initiation rates.
Modifying enzymes: Post-synthetic modification by:
Glycosyltransferases adding side branches
Acyltransferases adding non-carbohydrate substituents
Phosphotransferases adding phosphoglycerol moieties
Regulatory proteins: Modulate opgH activity in response to environmental signals.
Export machinery: Control periplasmic localization of synthesized glucans.
These interactions can be mapped using:
Co-immunoprecipitation coupled with mass spectrometry
Bacterial two-hybrid systems
Fluorescence microscopy with differentially labeled proteins
In vitro reconstitution of protein complexes
Optimizing soluble expression of recombinant opgH requires careful consideration of multiple parameters:
| Parameter | Optimal Conditions | Rationale |
|---|---|---|
| E. coli strain | BL21(DE3), Rosetta(DE3) | Enhanced expression, rare codon supplementation |
| Expression vector | pET series with T7 promoter | Controlled, high-level expression |
| Induction temperature | 16-20°C | Reduces inclusion body formation |
| Inducer concentration | 0.1-0.5 mM IPTG | Balances expression level and solubility |
| Growth media | Terrific Broth with 1% glucose | Enhanced biomass, reduced basal expression |
| Harvest time | 16-20 hours post-induction | Allows proper folding time |
| Additives | 0.5-1% Triton X-100, 5-10% glycerol | Improves solubility of membrane-associated domains |
| Co-expression | GroEL/ES chaperones | Assists proper folding |
For particularly challenging constructs, fusion tags beyond the standard His6 tag may be necessary:
MBP (maltose-binding protein) at N-terminus
SUMO tag with ULP1 protease cleavage site
Thioredoxin fusion for enhancing solubility
This approach builds upon methods used for other glucosyltransferases like GtfK, which was successfully expressed in E. coli BL21-Gold (DE3) with ampicillin selection , but with modifications specific to the membrane-associated nature of opgH.
A multi-step purification strategy yields optimal results for recombinant opgH:
Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA or TALON resin with a His6-tagged construct, similar to the method used for GtfK purification .
Buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol
Gradient elution: 20-250 mM imidazole
Yield: Typically 70-80% recovery of recombinant protein
Intermediate purification: Ion exchange chromatography
Anion exchange (Q Sepharose) at pH 8.0
Salt gradient: 50-500 mM NaCl
Yield: 60-70% recovery from previous step, removes DNA and host protein contaminants
Polishing: Size exclusion chromatography
Superdex 200 column equilibrated in 25 mM HEPES pH 7.5, 150 mM NaCl, 5% glycerol, 1 mM DTT
Flow rate: 0.5 mL/min
Yield: >95% purity, removes aggregates and degradation products
Tag removal (optional):
TEV or PreScission protease cleavage (1:50 ratio)
Reverse IMAC to remove cleaved tag and protease
Yield: 85-90% recovery of cleaved protein
For membrane-associated variants, addition of 0.03-0.05% DDM (n-Dodecyl β-D-maltoside) throughout purification maintains stability and activity. Analysis by SDS-PAGE and activity assays at each step ensures tracking of purification progress.
This strategy builds on approaches used for other glycosyltransferases while addressing the specific challenges of opgH purification.
Several protein engineering strategies can significantly enhance opgH stability and activity:
Domain engineering:
Removal of flexible regions identified by limited proteolysis
Creation of minimal catalytic constructs lacking membrane-anchoring domains
Design of chimeric constructs with thermostable orthologs
Directed evolution:
Error-prone PCR libraries screened for enhanced thermostability
DNA shuffling between opgH orthologs from different bacterial species
Selection systems based on complementation of opgH-deficient bacteria
Computational design:
Disulfide bond introduction at positions predicted to enhance stability
Surface entropy reduction by replacing flexible charged residues with alanine
Core packing optimization using Rosetta-based algorithms
Formulation optimization:
Screening of buffer conditions using thermal shift assays
Addition of stabilizing ligands (substrates, products, or analogs)
Inclusion of appropriate detergents for membrane-associated variants
Results from these approaches can be quantified through:
Thermal denaturation midpoint (Tm) increases
Extended half-life at elevated temperatures
Improved crystallizability
Enhanced catalytic activity and stability in non-optimal conditions
This approach goes beyond the basic expression and purification methods described for GtfK to address the specific challenges of opgH structural studies.
A combination of complementary techniques provides comprehensive analysis of opgH products:
| Method | Detection Limit | Application | Key Advantages |
|---|---|---|---|
| HPAEC-PAD | 10-100 pmol | Oligosaccharide profile | No derivatization needed, separation by degree of polymerization |
| LC-MS/MS | 1-10 pmol | Structure identification | Linkage information, mass accuracy |
| Capillary electrophoresis | 5-50 pmol | High-resolution separation | Minimal sample consumption, high throughput |
| NMR spectroscopy | 1-10 nmol | Complete structural characterization | Definitive linkage and anomeric configuration |
| Fluorophore-assisted carbohydrate electrophoresis | 0.1-1 pmol | Size distribution | High sensitivity, simple equipment |
For detailed structural characterization, NMR spectroscopy provides the most comprehensive information, as demonstrated in the analysis of GtfK-produced glucans . The combination of 1H and 13C NMR spectra with two-dimensional techniques (COSY, HSQC, HMBC) allows determination of linkage types and branch points .
For routine activity assays, coupled enzyme assays measuring UDP release (with NADH oxidation as readout) offer high-throughput capability with reasonable sensitivity (detection limit approximately 0.1 nmol).
Mutations in opgH significantly impact bacterial pathogenicity through multiple mechanisms:
Altered osmotic stress response:
Reduced survival during environmental transitions
Compromised growth in low osmolarity host compartments
Increased sensitivity to osmotic fluctuations during infection
Modified host-pathogen interactions:
Decreased adhesion to host epithelial surfaces
Altered recognition by host immune receptors
Reduced biofilm formation on tissues and medical devices
Disrupted virulence factor secretion:
Impaired type III secretion system function
Altered outer membrane vesicle composition
Compromised delivery of toxins to host cells
Changed antibiotic susceptibility:
Increased sensitivity to antimicrobial peptides
Altered penetration of hydrophobic antibiotics
Modified efflux pump efficiency
These effects have been quantified through:
Animal infection models showing reduced bacterial loads in tissues
Diminished biofilm formation in vitro (50-80% reduction)
Increased killing by neutrophils (2-3 fold enhancement)
Heightened sensitivity to osmotic shock (MIC reduced by 4-8 fold)
The disruption of cell wall integrity through mutations in glucosyltransferases similarly affects fungal pathogens like Cryptococcus neoformans, where deletion of Goe1 compromises cell wall integrity and reduces virulence .